Falak Angels syndicate invested in Saudi Arabia-based healthtech Thakaa Med’s Seed round.
ThakaaMed, an AI-driven healthcare solutions company founded in 2022 by Alwaleed Albadr, focuses on revolutionizing care through cutting-edge predictive, preventive, and personalized technology.
A Falak Angels syndicate helped Thakaa Med, a prominent AI-driven healthcare innovator and alumni, to obtain funding for its first seed round. The money will help Thakaa Med launch its flagship products, Dental IQ and Chest IQ, on the market and expedite the improvement of the company’s AI models.
“Falak Angels remains committed to supporting the next generation of tech startups, providing them with both financial and strategic resources to ensure their growth and impact,” said Adwa Aldakheel – CEO of Falak Investment Hub.
The goal of Falak Angels is to support entrepreneurs at the forefront of technological innovation, and this strategic investment is consistent with that goal.
Read also- Taiwan-Based DYXnet Merged with DYX Technology
By using this financing, ThakaaMed hopes to improve its AI technology, contribute to the Kingdom’s Vision 2030, and deliver creative solutions to the healthcare industry.
Using cutting-edge predictive, preventive, and personalized technologies to change healthcare, ThakaaMed is a leader in AI-driven healthcare solutions.
Read also- Singapore-Based Validus to Secures up to $50 Million in Debt Funding
Falak Angels facilitates investments by connecting astute investors with astute entrepreneurs. Falak Angels is a MENA-wide business accelerator that offers finance and strategic support to creative startups. It has over 180 startup alumni in its portfolio.
About Thakaa Med
ThakaaMed uses innovative technologies to transform healthcare. It is to move healthcare from reactive to predictive and proactive, ensuring that everyone receives timely, individualized, and effective care.
